20.51
-0.03 (-0.15%)
| Penutupan Terdahulu | 20.54 |
| Jumlah Dagangan | 212,892 |
| Harga / Pendapatan (P/E Ke hadapan) | 29.15 |
| Harga / Jualan (P/S) | 4.22 |
| Harga / Buku (P/B) | 3.33 |
| Julat 52 Minggu | |
| Hasil Dividen (DY TTM) | 0.30% |
| Margin Keuntungan | 11.16% |
| Margin Operasi (TTM) | 13.97% |
| EPS Cair (TTM) | 0.540 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 8.70% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 40.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 27.86% |
| Nisbah Semasa (MRQ) | 1.83 |
| Aliran Tunai Operasi (OCF TTM) | 184.02 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -113.47 M |
| Pulangan Atas Aset (ROA TTM) | 4.88% |
| Pulangan Atas Ekuiti (ROE TTM) | 9.14% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Bercampur | |
| Stok | Stevanato Group S.p.A. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | -2.0 |
| Purata | 0.14 |
|
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 1.68% |
| % Dimiliki oleh Institusi | 112.67% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Nicholas Company, Inc. | 30 Jun 2026 | 743,799 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Hasil Dividen (DY TTM) | 0.30% |
| Purata Hasil Dividen 4T | 0.19% |
| Nisbah Pembayaran | 11.52% |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 04 Jun 2024 | 10 Apr 2024 | 15 Jul 2024 | 0.0573 Tunai |
| 07 Jun 2023 | 05 Apr 2023 | 17 Jul 2023 | 0.0577 Tunai |
| 13 Jun 2022 | 11 Apr 2022 | 13 Jul 2022 | 0.0546 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2024 | 0.057 | 1 | 0.26 |
| 2023 | 0.058 | 1 | 0.21 |
| 2022 | 0.055 | 1 | 0.30 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |